BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26273291)

  • 21. MiR-30a attenuates osteoclastogenesis via targeting DC-STAMP-c-Fos-NFATc1 signaling.
    Yin Y; Tang L; Chen J; Lu X
    Am J Transl Res; 2017; 9(12):5743-5753. PubMed ID: 29312525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression.
    Zeng XZ; He LG; Wang S; Wang K; Zhang YY; Tao L; Li XJ; Liu SW
    Acta Pharmacol Sin; 2016 Feb; 37(2):255-63. PubMed ID: 26592521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decursin inhibits osteoclastogenesis by downregulating NFATc1 and blocking fusion of pre-osteoclasts.
    Kim KJ; Yeon JT; Choi SW; Moon SH; Ryu BJ; Yu R; Park SJ; Kim SH; Son YJ
    Bone; 2015 Dec; 81():208-216. PubMed ID: 26208796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
    Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH
    Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastrodin inhibits osteoclastogenesis via down-regulating the NFATc1 signaling pathway and stimulates osseointegration in vitro.
    Zhou F; Shen Y; Liu B; Chen X; Wan L; Peng D
    Biochem Biophys Res Commun; 2017 Mar; 484(4):820-826. PubMed ID: 28161640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα.
    Ma Z; Yu R; Zhao J; Sun L; Jian L; Li C; Liu X
    Inflamm Res; 2019 Feb; 68(2):157-166. PubMed ID: 30604211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethanolic extract of Schizonepeta tenuifolia attenuates osteoclast formation and activation in vitro and protects against lipopolysaccharide-induced bone loss in vivo.
    Kim JY; Baek JM; Ahn SJ; Cheon YH; Park SH; Yang M; Choi MK; Oh J
    BMC Complement Altern Med; 2016 Aug; 16(1):301. PubMed ID: 27550314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
    Dou C; Chen Y; Ding N; Li N; Jiang H; Zhao C; Kang F; Cao Z; Quan H; Luo F; Xu J; Dong S
    Osteoporos Int; 2016 Jul; 27(7):2335-2344. PubMed ID: 26809192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protocatechuic Acid Attenuates Osteoclastogenesis by Downregulating JNK/c-Fos/NFATc1 Signaling and Prevents Inflammatory Bone Loss in Mice.
    Park SH; Kim JY; Cheon YH; Baek JM; Ahn SJ; Yoon KH; Lee MS; Oh J
    Phytother Res; 2016 Apr; 30(4):604-12. PubMed ID: 26792397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulating calcium-mediated NFATc1 and mitogen-activated protein kinase deactivation underlies the inhibitory effects of kavain on osteoclastogenesis and bone resorption.
    Guo Q; Cao Z; Wu B; Chen F; Tickner J; Wang Z; Qiu H; Wang C; Chen K; Tan R; Gao Q; Xu J
    J Cell Physiol; 2018 Jan; 234(1):789-801. PubMed ID: 30078210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Rho GTPase Wrch1 regulates osteoclast precursor adhesion and migration.
    Brazier H; Pawlak G; Vives V; Blangy A
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1391-401. PubMed ID: 19135548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation.
    Dou C; Zhang C; Kang F; Yang X; Jiang H; Bai Y; Xiang J; Xu J; Dong S
    Biochim Biophys Acta; 2014 Nov; 1839(11):1084-96. PubMed ID: 25123438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arctigenin suppresses receptor activator of nuclear factor κB ligand (RANKL)-mediated osteoclast differentiation in bone marrow-derived macrophages.
    Kim AR; Kim HS; Lee JM; Choi JH; Kim SN; Kim DK; Kim JH; Mun SH; Kim JW; Jeon HS; Kim YM; Choi WS
    Eur J Pharmacol; 2012 May; 682(1-3):29-36. PubMed ID: 22387094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methotrexate inhibits osteoclastogenesis by decreasing RANKL-induced calcium influx into osteoclast progenitors.
    Kanagawa H; Masuyama R; Morita M; Sato Y; Niki Y; Kobayashi T; Katsuyama E; Fujie A; Hao W; Tando T; Watanabe R; Miyamoto K; Morioka H; Matsumoto M; Toyama Y; Saya H; Miyamoto T
    J Bone Miner Metab; 2016 Sep; 34(5):526-31. PubMed ID: 26202855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
    Lin X; Xiao Y; Chen Z; Ma J; Qiu W; Zhang K; Xu F; Dang K; Qian A
    Mol Cell Endocrinol; 2019 Aug; 494():110494. PubMed ID: 31260729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barley Seedling Extracts Inhibit RANKL-Induced Differentiation, Fusion, and Maturation of Osteoclasts in the Early-to-Late Stages of Osteoclastogenesis.
    Choi SW; Kim SH; Lee KS; Kang HJ; Lee MJ; Park KI; Lee JH; Park KD; Seo WD
    Evid Based Complement Alternat Med; 2017; 2017():6072573. PubMed ID: 28567098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dendritic cell-specific transmembrane protein DC-STAMP is essential for osteoclast fusion and osteoclast bone-resorbing activity.
    Miyamoto T
    Mod Rheumatol; 2006; 16(6):341-2. PubMed ID: 17164993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Artesunate suppresses RANKL-induced osteoclastogenesis through inhibition of PLCγ1-Ca
    Zeng X; Zhang Y; Wang S; Wang K; Tao L; Zou M; Chen N; Xu J; Liu S; Li X
    Biochem Pharmacol; 2017 Jan; 124():57-68. PubMed ID: 27789216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors.
    Ohyama Y; Ito J; Kitano VJ; Shimada J; Hakeda Y
    PLoS One; 2018; 13(1):e0191192. PubMed ID: 29342179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-218 is involved in the negative regulation of osteoclastogenesis and bone resorption by partial suppression of p38MAPK-c-Fos-NFATc1 signaling: Potential role for osteopenic diseases.
    Qu B; Xia X; Yan M; Gong K; Deng S; Huang G; Ma Z; Pan X
    Exp Cell Res; 2015 Oct; 338(1):89-96. PubMed ID: 26216483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.